LCNEC-ALPINE (#1345)
Laufzeit: 01.01.2021 - 31.12.2040
imported
Kurzfassung
A Phase II, single-arm trial of Atezolizumab/Platinum/Etoposide for the treatment of advanced large-cell neuroendocrine cancer of the lung
Laufzeit: 01.01.2021 - 31.12.2040
A Phase II, single-arm trial of Atezolizumab/Platinum/Etoposide for the treatment of advanced large-cell neuroendocrine cancer of the lung